Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.5K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
PPE Use in Healthcare Settings II: Doffing01:10

PPE Use in Healthcare Settings II: Doffing

1.6K
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.

Advances in therapy·2026
Same author

Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Re-evaluating the Potential Impact of Preexposure Prophylaxis (PrEP) in Achieving HIV Elimination in the United States: Insights From Modeling.

Open forum infectious diseases·2026
Same author

State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial.

Journal of public health (Oxford, England)·2025
Same author

Increased Reporting of Infants Born With Congenital Syphilis to a Local Department of Public Health: A Quality Improvement Project.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Jan 18, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.8K

Perspectives of Doxycycline Postexposure Prophylaxis Among Pediatric Providers.

John M Flores, Trenton Lam1, Jose L Paredes Sosa2

  • 1Pritzker School of Medicine of University of Chicago.

Sexually Transmitted Diseases
|May 23, 2025
PubMed
Summary

Pediatric providers report low comfort with doxycycline postexposure prophylaxis (DoxyPEP), a potential tool to reduce sexually transmitted infections in adults. Barriers to DoxyPEP use need to be addressed for effective implementation.

More Related Videos

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.1K

Related Experiment Videos

Last Updated: Jan 18, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.8K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.1K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pediatrics

Background:

  • Doxycycline postexposure prophylaxis (DoxyPEP) is a chemoprophylaxis strategy.
  • It shows potential in reducing certain sexually transmitted infections (STIs) among high-priority adult groups.
  • Limited data exists on its adoption and perceived barriers within pediatric healthcare settings.

Purpose of the Study:

  • To assess pediatric providers' familiarity and comfort levels with DoxyPEP.
  • To identify barriers hindering the implementation of DoxyPEP in pediatric practice.
  • To understand the current landscape of DoxyPEP knowledge among US pediatric providers.

Main Methods:

  • A cross-sectional survey was conducted.
  • The study included 167 pediatric providers in the United States.
  • Data on provider comfort, familiarity, and perceived barriers were collected.

Main Results:

  • Approximately 40% of surveyed pediatric providers reported lacking comfort and familiarity with DoxyPEP.
  • Various barriers to the use of DoxyPEP were identified by the providers.
  • This indicates a significant gap in knowledge and readiness for DoxyPEP implementation.

Conclusions:

  • There is a notable lack of comfort and familiarity with DoxyPEP among pediatric providers.
  • Addressing identified barriers is crucial for the successful integration of DoxyPEP into pediatric care.
  • Further education and resources are needed to support providers in utilizing DoxyPEP effectively.